Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Checkpoint Therapeutics, Inc. (CKPT)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/25/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 80.9k | $0.00 | $0 | | 09/25/2023 |
| 06/30/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 81.4k | $0.00 | $0 | | 06/30/2023 |
| 06/13/2023 | Boilen Scott | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | Bechon Christian | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | Herskowitz Neil | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | SALZMAN BARRY M | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | WEISS MICHAEL S | Director | Grant | COMMON STOCK | 17.5k | $0.00 | $0 | See Note 3 | 06/13/2023 |
| 04/04/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 42.5k | $0.00 | $0 | | 03/31/2023 |
| 03/31/2023 | GRAY WILLIAM GARRETT | CFO | Grant | Common Stock (Restricted) | 100k | $0.00 | $0 | | 03/31/2023 |
| 03/31/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 35.7k | $0.00 | $0 | | 03/31/2023 |
| 03/31/2023 | Oliviero James F III | CEO, President and Director | Grant | COMMON STOCK (RESTRICTED) | 250k | $0.00 | $0 | | 03/31/2023 |
| 03/02/2023 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 5.5k | $5.00 | $27.4k | | 02/27/2023 |
| 03/02/2023 | GRAY WILLIAM GARRETT | CFO | Sale | Common Stock | 3.6k | $5.00 | $18k | | 02/27/2023 |
| 02/27/2023 | GRAY WILLIAM GARRETT | CFO | Sale | Common Stock | 1.9k | $4.66 | $8.9k | | 02/27/2023 |
| 02/27/2023 | GRAY WILLIAM GARRETT | CFO | Grant | Common Stock | 7.5k | $0.00 | $0 | | 02/27/2023 |
| 02/27/2023 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 5.5k | $4.65 | $25.8k | | 02/27/2023 |
| 02/27/2023 | Oliviero James F III | CEO, President and Director | Grant | COMMON STOCK | 15k | $0.00 | $0 | | 02/27/2023 |
| 02/01/2023 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 10.3k | $4.77 | $48.9k | | 02/01/2023 |
| 02/01/2023 | GRAY WILLIAM GARRETT | CFO | Sale | Common Stock | 3.2k | $4.79 | $15.1k | | 02/01/2023 |
| 01/10/2023 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 3.8k | $6.75 | $25.8k | | 01/10/2023 |
| 01/10/2023 | GRAY WILLIAM GARRETT | CFO | Sale | Common Stock | 1.9k | $6.75 | $12.5k | | 01/10/2023 |
| 01/05/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 368.9k | $0.00 | $0 | | 01/05/2023 |
| 06/23/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 15k | $1.11 | $16.6k | | 06/17/2022 |
| 06/22/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 12k | $1.09 | $13.1k | | 06/17/2022 |
| 06/21/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 21k | $1.09 | $22.9k | | 06/17/2022 |
| 06/17/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 228k | $1.09 | $248.5k | | 06/17/2022 |
| 06/16/2022 | Boilen Scott | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Bechon Christian | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Herskowitz Neil | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | SALZMAN BARRY M | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | WEISS MICHAEL S | Director | Grant | COMMON STOCK | 47.6k | $0.00 | $0 | See Note 3 | 06/16/2022 |
| 04/13/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 21.3k | $1.51 | $32.1k | | 01/01/2022 |
| 04/05/2022 | Oliviero James F III | CEO, President and Director | Sale | COMMON STOCK | 14k | $1.77 | $24.8k | | 01/01/2022 |
|
|